Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status-Reference-Cited by-同舟云学术

Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status

Published:2017-11 Issue:5 Volume:77 Page:893-901
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Helgadottir Hildur,Tuominen Rainer,Olsson Håkan,Hansson Johan,Höiom Veronica

Publisher

Elsevier BV

Subject

Dermatology

Reference25 articles.

1. Ten-year survival after multiple invasive melanomas is worse than after a single melanoma: a population-based study;Youlden;J Invest Dermatol,2016

2. Eleven primary melanomas, colon cancer, and atypical nevi in the same patient: a case report and literature review;Juul Nielsen;Case Rep Dermatol Med,2016

3. Risk of next melanoma in patients with familial and sporadic melanoma by number of previous melanomas;Chen;JAMA Dermatol,2015

4. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas;Hashemi;Cancer Res,2000

5. CDKN2A mutations in multiple primary melanomas;Monzon;N Engl J Med,1998

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the Germline Genome Encode for the Invasiveness of a Cutaneous Melanoma?;JAMA Dermatology;2024-08-14

2. Retrospective study of germline variants in patients with hereditary melanoma study criteria in a real clinical practice setting;Clinical and Experimental Dermatology;2024-06-04

3. Endoplasmic reticulum stress regulators exhibit different prognostic, therapeutic and immune landscapes in pancreatic adenocarcinoma;Journal of Cellular and Molecular Medicine;2024-02

4. Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis;Melanoma Research;2023-11-02

5. Familial features affecting the melanoma risk in CDKN2A -negative melanoma families: a study based on the Swedish Cancer Registry;Acta Oncologica;2023-10-06